UniSuper Management Pty Ltd Has $1.85 Million Stock Holdings in Globe Life Inc. $GL

Key Points

• UniSuper Management Pty Ltd reduced its stake in Globe Life Inc. by 12.3%, selling 1,976 shares and holding 14,041 shares valued at approximately $1.85 million as of the latest SEC filing.
• Globe Life reported earnings of $3.27 per share for the most recent quarter, surpassing analysts' expectations, and has set a FY 2025 EPS guidance of 14.250-14.650.
• The company announced a quarterly dividend of $0.27 per share, with an ex-dividend date on October 3rd, representing an annualized yield of 0.8%.

UniSuper Management Pty Ltd reduced its stake in Globe Life Inc. (NYSE:GL - Free Report) by 12.3% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 14,041 shares of the company's stock after selling 1,976 shares during the period. UniSuper Management Pty Ltd's holdings in Globe Life were worth $1,849,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. Dimensional Fund Advisors LP boosted its stake in Globe Life by 9.3% in the first quarter. Dimensional Fund Advisors LP now owns 1,741,131 shares of the company's stock valued at $229,323,000 after acquiring an additional 148,397 shares during the period. Jacobs Levy Equity Management Inc. boosted its stake in Globe Life by 35.9% in the first quarter. Jacobs Levy Equity Management Inc. now owns 1,025,984 shares of the company's stock valued at $135,143,000 after acquiring an additional 271,253 shares during the period. Nuveen LLC acquired a new position in shares of Globe Life during the first quarter worth approximately $131,608,000. GAMMA Investing LLC boosted its position in shares of Globe Life by 15,553.5% during the first quarter. GAMMA Investing LLC now owns 781,890 shares of the company's stock worth $102,991,000 after buying an additional 776,895 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of Globe Life by 0.4% during the first quarter. Charles Schwab Investment Management Inc. now owns 781,409 shares of the company's stock worth $102,927,000 after buying an additional 3,312 shares during the period. 81.61% of the stock is currently owned by institutional investors and hedge funds.

Globe Life Price Performance

Shares of NYSE GL traded down $1.39 during trading on Tuesday, hitting $141.04. The company had a trading volume of 525,575 shares, compared to its average volume of 429,503. The company has a market cap of $11.42 billion, a P/E ratio of 11.27 and a beta of 0.56. Globe Life Inc. has a 52 week low of $100.27 and a 52 week high of $144.00. The business's 50-day moving average is $135.25 and its 200 day moving average is $126.96. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.06 and a current ratio of 0.06.

Globe Life (NYSE:GL - Get Free Report) last posted its quarterly earnings results on Wednesday, July 23rd. The company reported $3.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.25 by $0.02. The company had revenue of $1.48 billion for the quarter, compared to analysts' expectations of $1.50 billion. Globe Life had a return on equity of 21.24% and a net margin of 18.11%.The firm's revenue was up 2.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.97 earnings per share. Globe Life has set its FY 2025 guidance at 14.250-14.650 EPS. Equities research analysts predict that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.

Globe Life Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, October 3rd will be paid a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Friday, October 3rd. Globe Life's payout ratio is 8.63%.

Insider Activity

In other Globe Life news, CEO Frank M. Svoboda sold 12,500 shares of the business's stock in a transaction on Thursday, July 31st. The shares were sold at an average price of $141.38, for a total transaction of $1,767,250.00. Following the sale, the chief executive officer directly owned 32,747 shares of the company's stock, valued at $4,629,770.86. The trade was a 27.63% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Thomas Peter Kalmbach sold 28,952 shares of the business's stock in a transaction on Tuesday, July 29th. The shares were sold at an average price of $140.97, for a total transaction of $4,081,363.44. Following the sale, the chief financial officer directly owned 30,665 shares in the company, valued at approximately $4,322,845.05. This trade represents a 48.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 84,722 shares of company stock valued at $11,733,793 in the last 90 days. Company insiders own 1.97% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on GL. Wells Fargo & Company boosted their price objective on Globe Life from $144.00 to $150.00 and gave the stock an "overweight" rating in a research report on Friday, July 25th. Truist Financial began coverage on Globe Life in a research report on Tuesday, July 15th. They set a "buy" rating and a $150.00 price objective for the company. Keefe, Bruyette & Woods boosted their price objective on Globe Life from $145.00 to $155.00 and gave the stock an "outperform" rating in a research report on Monday, July 28th. Morgan Stanley boosted their target price on Globe Life from $166.00 to $171.00 and gave the stock an "overweight" rating in a report on Monday, August 18th. Finally, JPMorgan Chase & Co. boosted their target price on Globe Life from $145.00 to $160.00 and gave the stock an "overweight" rating in a report on Tuesday, July 8th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $152.45.

Globe Life Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.